System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Elodie Bohers is an expert in Hematology at Centre Henri Becquerel (France). Elodie Bohers has authored 76 publications, the most recent in 2026. SLR score: 162 (community average: 125). How the SLR is computed.

LeadR Profile

Elodie Bohers Centre Henri Becquerel France
162 ScienceLeadR Reputation 162

Unlock

Register Login
Network Map

Hematology

Subspecialties: Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Normandie Université

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 76

Citations

Citations: 1 979 1st author: 12 Last author: 0 Unique author: 0

Main journals

Blood 12
HAL (Le Centre pour la Communication Scientifique Directe) 8
Leuk Lymphoma 5
Blood Adv 3
Genes Chromosomes Cancer 3

Best Journals

Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.
PMID 41979332 — cells, circulating tumor dna, lymphoma, b-cell, lymphoma, neoplasms, predictive value of tests, therapeutics, dna, b-lymphocytes		Blood Adv20260
Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.
PMID 41964148 — cells, genes, circulating tumor dna, carcinoma, squamous cell, neoplasms, squamous cell carcinoma of head and neck, dna		Int J Cancer20260
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA.
PMID 40166656 — cells, lymphoma, b-cell, lymphoma, lymphoma, large b-cell, diffuse, aged, rituximab, therapeutics, b-lymphocytes		EClinicalMedicine20250
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACE.
PMID 39293080 — cells, genes, lymphoma, b-cell, lymphoma, neoplasms, b-lymphocytes, hematologic diseases, prognosis		Blood Adv20241
Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma.
PMID 38435425 — cells, lymphoma, follicular, biological evolution, lymphoma, pathology, immunoglobulins, therapeutics, t-lymphocytes, receptors, antigen, t-cell, rna		Hemasphere20240

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS